Neither Cephalexin Nor Levofloxacin Should Be Used for Enterococcus faecalis Infections
Cephalexin is completely ineffective against Enterococcus faecalis and should never be used. Levofloxacin has poor activity with high resistance rates (46-47%) and is not recommended as monotherapy for enterococcal infections 1.
Why These Antibiotics Fail
Cephalexin (First-Generation Cephalosporin)
- Enterococci have intrinsic resistance to cephalosporins - this is a fundamental microbiological principle
- The FDA label for cephalexin 2 lists approved indications but notably excludes any enterococcal infections
- Cephalosporins lack binding affinity to enterococcal penicillin-binding proteins, rendering them ineffective regardless of dose
Levofloxacin (Fluoroquinolone)
- While the FDA label 3 indicates levofloxacin covers E. faecalis for complicated skin/skin structure infections and chronic bacterial prostatitis, this does not extend to other infection types
- High resistance rates: 46-47% of E. faecalis strains are fluoroquinolone-resistant in complicated UTIs 1
- In vitro studies show variable activity with MIC90s often in the resistance range 4
- No synergy demonstrated: Combination with vancomycin shows indifferent or minimal synergistic activity 5
- Research shows levofloxacin is "no longer a recommended therapy for E. faecalis from complicated UTI in men with risk factors" 1
Appropriate Treatment Options for E. faecalis
The correct first-line therapy depends on infection severity and site:
For Serious Infections (Endocarditis, Bacteremia)
- Ampicillin 2g IV every 4 hours PLUS gentamicin (if aminoglycoside-susceptible) 6
- Alternative: Double β-lactam therapy with ampicillin plus ceftriaxone or ceftaroline for aminoglycoside-resistant strains 6, 7
- Duration: 4-6 weeks depending on valve involvement 6
For Urinary Tract Infections
- Ampicillin remains effective even for ampicillin-resistant VRE in UTIs due to high urinary concentrations (18-30g IV daily or amoxicillin 500mg PO/IV every 8 hours) 8
- Fosfomycin - FDA-approved specifically for E. faecalis UTI 8
- Nitrofurantoin - good in vitro activity for lower UTI 8
- Ampicillin/sulbactam - recommended alternative for ciprofloxacin-resistant strains 1
For Vancomycin-Resistant E. faecalis (VRE)
- Daptomycin 8-12 mg/kg/day (preferred for bactericidal activity) 8
- Linezolid (bacteriostatic) 6, 8
- Tigecycline for intra-abdominal infections 8
Critical Clinical Pitfalls
- Never use any cephalosporin alone for enterococcal infections - this is microbiological futility
- Avoid fluoroquinolones as empiric therapy given 46-47% resistance rates 1
- Risk factors for fluoroquinolone resistance include hospital-acquired infection (OR 18.15), urological department treatment (OR 6.15), and transfer from healthcare centers (OR 7.39) 1
- Differentiate colonization from true infection before initiating anti-enterococcal therapy 8
- For β-lactamase-producing E. faecalis (rare), use ampicillin-sulbactam instead of ampicillin alone 6
The Bottom Line
Use ampicillin-based regimens (with or without aminoglycosides/ceftriaxone depending on resistance patterns and infection severity) as first-line therapy for E. faecalis. Both cephalexin and levofloxacin are inappropriate choices - cephalexin due to intrinsic resistance and levofloxacin due to high resistance rates and lack of guideline support for most enterococcal infections 6, 8, 1.